title: [Clinical application of the plasma substitutes in patients with postoperative complications after surgeries for brain meningioma].
abstract: The issues on optimization of the restoration treatment of patients, suffering the brain meningioma, were discussed, basing on analysis of 498 observations. Tactics of the patients management in noncomplicated, complicated and severe course of postoperative period is adduced. The indices of survival and lethality, peculiarities of the infusion therapy were analyzed. The role of plasm-restituting preparations was demonstrated in complicated course of postoperative period. Rational complex approach to the restoration measures and intensive therapy conduction promotes the treatment efficacy raising, the patients fair quality of life securing in the brain meningioma in postoperative period.
authors.forename: M S
authors.initials: MS
authors.lastname: Kvasha
authors.forename: R Iu
authors.initials: RIu
authors.lastname: Iarotskiĭ
authors.forename: V I
authors.initials: VI
authors.lastname: Ivashenko
authors.forename: R V
authors.initials: RV
authors.lastname: Gavrish
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Dmitrieva
authors.forename: I N
authors.initials: IN
authors.lastname: Ivanovich
authors.forename: T M
authors.initials: TM
authors.lastname: Pushkareva
mesh_terms: D016063:Blood Loss, Surgical / Q000503:physiopathology; D005260:Female; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage* / Q000009:adverse effects; D020896:Hypovolemia / Q000401:mortality / Q000517:prevention & control*; D008297:Male; D008577:Meningeal Neoplasms / Q000097:blood / Q000401:mortality / Q000601:surgery*; D008579:Meningioma / Q000097:blood / Q000401:mortality / Q000601:surgery*; D059035:Perioperative Period; D010951:Plasma Exchange / Q000379:methods; D010952:Plasma Substitutes / Q000008:administration & dosage* / Q000009:adverse effects; D011183:Postoperative Complications / Q000401:mortality / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes